BioCentury
ARTICLE | Company News

Boehringer, China Southeast University deal

December 2, 2016 9:07 PM UTC

Boehringer said it will collaborate with the university's Institute of Life Sciences to develop regenerative therapies to treat hearing loss. The collaboration is part of Boehringer's Research Beyond Borders (RBB) program, designed to incubate promising technologies that could complement the company's core therapeutic areas but do not yet fit into any of its ongoing programs...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Boehringer Ingelheim GmbH